Advertisement
Canada markets closed

  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    85,715.35
    -2,660.82 (-3.01%)
     

  • CMC Crypto 200

    1,307.34
    -89.19 (-6.39%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     

  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Five Star Equities Issues New Research Reports on CAS, CUR, FAST and LRN

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

A.M. Castle and Co. (NYSE:CAS - News) shares dropped 10.01 percent to close at $14.75 a share last Wednesday. The stock traded between $14.30 and $15.52 on volume 478,685 shares traded. The company expects to report a net loss of approximately $0.28 to $0.32 per diluted share for the third quarter of 2013. Shares of A.M. Castle and Co. have gained approximately 16.0 percent year-to-date.

Get more information on A.M. Castle and Co. free access to the in-depth equity report at:
www.FiveStarEquities.com/CAS

Neuralstem, Inc. (NYSEMKT:CUR - News) shares spiked 13.12 percent to close at $2.50 a share last Wednesday. The stock traded between $2.07 and $2.61 on volume of 1.79 million shares traded. The company announced that the University of Michigan Health System has treated its first two patients in the Phase II trial testing NSI-566 neural stem cells in amyotrophic lateral sclerosis. Shares of Neuralstem have gained approximately 130.0 percent year-to-date.

ADVERTISEMENT

Get more information on Neuralstem and free access to the in-depth equity report at:
www.FiveStarEquities.com/CUR

Fastenal Company (NASDAQ:FAST - News) shares declined 6.26 percent to close at $46.85 a share last Wednesday. The stock traded between $45.85 and $48.52 on volume of 6.64 million shares traded. The company reported net sales of $858.4 million for the third quarter of 2013, an increase of 7.0 percent when compared to a year ago.

Get more information on Fastenal and free access to the in-depth equity report at:
www.FiveStarEquities.com/FAST

K12 Inc. (NYSE:LRN - News) shares plunged 38.44 percent to close at $17.60 a share last Wednesday. The stock traded between $17.15 and $21.37 on volume of 5.31 million shares traded. The company announced that average student enrollments for the first quarter of fiscal 2014 were below management’s expectations. Shares of K12 have fallen approximately 14.0 percent year-to-date.

Get more information on K12 and free access to the in-depth equity report at:
www.FiveStarEquities.com/LRN

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com